This Solicitation opportunity from Department Of Defense was posted on August 26, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

BENZONATATE CAPSULES

Closed

SPE2DP-26-T-4764Federal

Submission Closed09/01/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

BENZOCAINE ORAL TOPICA

Solicitation # SPE2DP-27-T-0076

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0079

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-27-T-0080

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0077

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0081

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Radiopharmaceutical Cold Kit and Unit Dose SupplierThis subcontract involves the manufacture and supply of radiopharmaceutical kits and unit doses to support prime contractors on Department of Veterans Affairs nuclear medicine projects. The scope of work includes providing Cold Kits such as MAA, MDP, Mebrofenin, and PYP, as well as Tc99m, I-123, and In-111 variants. Additionally, the supplier must provide bar-labeled inserts that are compatible with the PineStar Nuclear Medicine Information Management System, with all deliveries directed to secure location room 3A101B. To qualify for this contract, the provider must maintain a valid NRC license and accreditation while ensuring full compliance with DOT, NHPP, FDA, and OSHA regulations. Managed by the Department of Veterans Affairs Network Contract Office 4, the project falls under NAICS code 325412 and is centered in the 19104 zip code area.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center

Solicitation # 36C24427Q0018

The Department of Veterans Affairs, Network Contracting Office 4, is soliciting quotations for an indefinite-quantity contract to provide essential radiopharmaceuticals and calibration sources for the Corporal Michael J. Crescenz VA Medical Center Nuclear Medicine Department. The contract covers a five-year period of performance from November 1, 2026, to October 31, 2031, consisting of a base year and four option years. The selected vendor must be licensed and accredited by the Nuclear Regulatory Commission and comply with all regulations from the DOT, NHPP, FDA, and OSHA. Deliveries are to be made to a secure location at the medical center, with routine orders due by 8:00 AM the following workday and same-day deliveries required within two hours of order placement during normal business hours. The scope of work includes the supply of various radiopharmaceutical kits and calibration sources, such as Co57 and Tc99m variants. Contractors must ensure all radioactive materials are clearly labeled with proper class and exposure levels, and unit doses must include preparation and expiration details. Additionally, the vendor must provide bar-labeled inserts compatible with the PineStar Nuclear Medicine Information Management System or provide a compatible system, including data migration and training, at no additional cost. Award will be based on a comparative evaluation of price and past performance, with a preference for HUBZone Small Business Concerns. Quotations must be submitted electronically to the Contracting Officer in two parts: a price quotation and past performance information from the last three years. Invoicing is to be handled monthly and submitted electronically via the Austin Payment Center.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

Solicitation # HT9402-26-Q-9404

Defense Health Agency (dha)

POSTED

DEADLINE

Solicitation # HT940827Q0002

The Defense Health Agency intends to award a sole source contract to INO Therapeutics LLC for the procurement and delivery of Inhaled Nitric Oxide for the Department of Medicine at Brooke Army Medical Center in Fort Sam Houston, Texas. The contract covers a base period from January 1, 2027, to December 31, 2027, with four additional option years. The scope of work includes the supply of 800 PPM nitric oxide for inhalation, a specialized delivery device, all necessary maintenance and calibration accessories, and comprehensive support services such as training and logistics. This notice serves as a sources-sought inquiry to determine if other capable vendors exist before finalizing the sole source award. Interested parties must submit written evidence of their capability to meet all technical requirements to Contracting Officer Joe D. Wells by October 22, 2026, at 12:00 PM CST. Submissions must demonstrate that competition would be beneficial to the government without being cost or schedule prohibitive.

Defense Health Agency

POSTED

DEADLINE

Blood Cell Staining Kit SupplierThis subcontract involves the supply of specialized Blood Cell Staining Kits for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The required kits must feature Wright's stain compatible with Ames Hematek slide stainers, utilizing Romanowski type modified polychrome methylene blue or thiazine and xanthine dyes. All products must adhere to MIL-STD-2073-1E and Medical Marking Standard No. 1. Key operational requirements include a strict manufacture-to-delivery timeline of one month and a minimum shelf life of 12 months. The contract specifies the delivery of one kit on a FOB Destination basis to a performance location in FPO 09566-4008. The opportunity is categorized under NAICS code 325412.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Dextrose Injection SupplierThis subcontract involves the supply of 3,328 units of FDA-regulated Dextrose Injection 5%, 100 ML for prime contractors supporting Department of Defense DLA Troop Support Medical Supply Chain projects. The selected supplier must manufacture or source the product from FDA-approved facilities, ensuring a minimum shelf life of 24 months and strict adherence to Medical Marking Standard No. 1 and MIL-STD-2073-1E. The agreement requires full compliance with the Buy American Act and the Berry Amendment, with delivery terms set as FOB Destination to APO 09227-0000. This procurement falls under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Heparin Sodium Injection, USP SupplierThis subcontract involves the supply of FDA-regulated Heparin Sodium Injection, USP, to prime contractors supporting Department of Defense supply contracts through the Medical Supply Chain Pharm FSA. The scope of work requires the manufacture or distribution of 5000 unit/1ml single-use Carpuject injections, packaged in boxes of 50, under NSN 6505-01-659-1547. All products must strictly adhere to USP standards and comply with the Buy American Act. Key delivery requirements include ensuring a minimum shelf life of 21 months upon receipt. The place of performance is designated as Travis AFB. Interested parties must respond by October 13, 2026, in accordance with the solicitation guidelines for NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

4 days ago

DEADLINE

in 2 days

AI Contract Overview

This contract is for the procurement of Benzonatate Capsules, USP, 100 mg, provided in bottles of 100 units. The medication is regulated by the FDA and must be stored at a controlled room temperature between 20 and 25 degrees Celsius, protected from light, moisture, and humidity. The item carries a non-extendable shelf life of 36 months and must adhere to specific DLA packaging and medical marking standards. The order consists of one bottle under solicitation SPE2DP-26-T-4764, with delivery required within five days after the order. The contract specifies delivery, inspection, and acceptance at the destination point with a zero percent quantity variance. It incorporates various technical and quality requirements from the DLA master list and requires the removal of government identification from any non-accepted supplies.

General Info

Procurement of one bottle of Benzonatate 100mg capsules under solicitation SPE2DP-26-T-4764.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

USA

Set-Aside

NONE

Documents

SPE2DP-26-T-4764 Request for Quotations

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedAug 26

Solicitation

Response DeadlineSep 1

Deadline has passed

Submission Closed

09/01/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

IMERAH BURNETT

contact@example.gov

+1 (555) 000-0000

Full Description

BENZONATATE CAPSULES
BENZONATATE CAPSULES,USP, 100 MG, 100'S. 100 MILLIGRAMS OF BENZONATATE
ACTIVE INGREDIENT.UNIT OF ISSUE: BOTTLE (BT) OF 100ea. The capsules should be protected from light, moisture and humidity, and stored at controlled room temperature 20° to 25°C (68° to 77°F).
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
AVKARE LLC 4QGW8 P/N NDC42291-0091-01 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC60429-0927-01 PROFICIENT RX LP 7GU24 P/N NDC71205-0885-00
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018034594 0001 BT 1.000
NSN/MATERIAL:6505006601798
SPE2DP-26-T-4764
SECTION B
PR: 7018034594 PRLI: 0001 CONT’D
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-660-1798 Quantity: 1 BT Purchase Request: 7018034594QTY: 1 Delivery: 5 days ADO